When compared to those taking topiramate, GLP-1 users were: 48% less likely to start valproate 42% less likely to start calcitonin gene-related peptide (CGRP) monoclonal antibodies 35% less likely to start tricyclic antidepressants 23% less likely to start the class of drugs called gepants However, there was no significant difference between the two groups, and the need to begin taking beta-blockers
Rare but severe side effects include digestive, kidney, and thyroid issues, hair loss, rapid heart rate, vision problems, and mental health concerns
I believe that its reasonable to conclude that [my prediabetes] was much worse than the potential risk. Understanding the Dangers There are, of course, many reasons why drug preparation and distribution are reserved for trained and certified professionals
Bottom line: While Wegovy has the backing of large-scale clinical trials for its specific formulation, compounded semaglutide provides a safe, regulated alternative that uses the same active molecule to support weight loss goals
Nurse Destiny and Sandra were excellent